DOCSLIB.ORG

Product List

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Product List Arena Product List A Cabazitaxel (Under Development) Acebutolol HCl Calcitriol N-Acetyl-L-Asparagine Calcifediol N-Acetyl-L-Aspartic Acid Calcipotriol Monohydrate Acexamic Acid (Upon Request) Canrenoate K Aesculin Canrenone micronised Agomelatine (Under Development) Capecitabine Alfacalcidol Captopril Alimemazine Tartrate Carbamizole Aliskiren Fumarate (Under Development) Carbasalate Calcium Altizide Carbomers Amcinonide Acetyl Thiazolidin Carboxylic Acid Amifostine L-Carnitine Base Amiodarone HCl (Upon Request) Acetyl-L-Carnitine HCl Amisulpride (Upon Request) Acetyl Carnosine Amitriptyline HCl L-Carnosine Apomorphine HCl Cefaclor L-Arginine Base Cefalexin Monohydrate L-Arginine-L-Aspartate Cefamandole Nafate Sterile L-Arginine-L-Glutamate Cefazedone Sodium Sterile Aripiprazole (Under Development) Cefepime HCL Artesunate (Upon Request) Cefmetazole Artemether (Upon Request) Cefmetazole Sodium Sterile Articaine HCl Cefminox Sodium Sterile L-Asparagine Anyhdrous Cefodizime Disodium L-Asparagine Monohydrate Cefodizime Sodium Sterile DL-Aspartic Acid Magnesium Salt Cefotetan DL-Aspartic Acid Magnesium + Potassium Salt Cefotetan Sodium Sterile DL-Aspartic Acid Potassium Salt Cefozopran (Under Development) L-Aspartic Acid Sodium Salt Monohydrate Cefsulodin (Under Development) Atovaquone (Under Development) Cefsulodin Sodium Sterile Azacitidine (Under Development) Cefuroxime Sodium Azathioprine Powder Cefuroxime Sodium Sterile Centella Asiatica Extract B Cephacetrile Sodium Sterile Baclofen Cetirizine HCl Beclomethasone Base Cetrimide Powder Beclomethasone Dipropionate Cetrimide 40% Solution in IPA Beclomethasone Dipropionate Monohydrate Cetylpyridinium Chloride Bendamustine HCl Chloral Hydrate Bendroflumethiazide Chlorbutol (Chlorbutanol) Benzalkonium Chloride 50% Solution Chlorhexidine DiHCl Benzethonium Chloride Chlormadinone Acetate Benzyl Benzoate Chlorpromazine HCl Bergapten Cholecalciferol Betamethasone Acetate Cholestyramine Betamethasone Acetate Sterile Ciclopirox Acid Powder (Upon Request) Betamethasone Dipropionate Ciclopirox Olamine Powder (Upon Request) Betamethasone Valerate Cinacalcet Betaxolol HCl Cinchocaine Base (Dibucaine Base) Bilberry Extract Cinchocaine HCl (Dibucaine HCl) Bisacodyl Ciprofibrate (Upon Request) Bortezomib Cladribine (Under Development) Bosentan Monohydrate Clindamycin Phosphate Budesonide Clobazam (Upon Request) Budesonide Micronized Clobetasol Propionate Budesonide R Clobetasone Butyrate Budesonide Sterile Clocortolone Pivalate Buflomedil HCl Clonazepam Bupivacaine HCl Clofarabine (Under Development) Buprenorphine HCl Clorazepate Dipotassium (Upon Request) Buserelin Acetate (Upon Request) Codeine Base Busulfan Codeine Camphosulfonate Butopiprine Hydrobromide Codeine Hydrochlorure Codeine Phosphate Hemihydrate Codeine Resinate C Concentrate of Poppy Straw (Morphine) Arena Pharmaceuticals Ltd, Unit 14 Apollo Office Court, Radclive Road, Gawcott, Buckingham, MK18 4DF Tel: + 44 1280 824 200 www.arenapharmaceuticals.co.uk email: [email protected] Arena Product List Concentrate of Poppy Straw (Thebaine) Framycetin Sulphate (non-micro) Cortisone Acetate Framycetin Sulphate Low Bio Burden Creatinine Fulvestrant Cyanocobalamin Furosemide Cyproterone Acetate G D Gefitinib 24r-25dihydroxicholecalciferol Gemcitabine Dantrolene Sodium Ginger Dry Extract (40 Mesh) Decitabine (Under Development) Gingko Biloba Extract EPG246 Deet (N, N-Diethyl-M-Toluamide) Glimepiride (Upon Request) Deflazacort Glycopyrrolate Deflazacort Micronized Gonadorelin Acetate (Upon Request) Delmadinone Acetate Glucosamine HCl Deltamethrin Glucosamine Sulphate Desonide N-Acetyl-L-Glutamine Desonide Phosphate Desoximetasone micronized H Dexamethasone micronized Halcinonide Dexamethasone Sodium Metasulfobenzoate Halobetasol Propionate Dexamethasone Acetate micronized Halomethasone Dexamethasone Sodium Phosphate HMRlignan™ Dexamfetamine Sulfate Hexetidine 3,4-Diaminopyridine Human Recombinant Insulin (Upon Request) Diazoxide Hydrocortisone Micronized Dihydrotachysterol-2 (DHT2) Hydrocortisone Acetate Diflorasone Diacetate Hydrocortisone Acetate micronized Diflucortolone Valerate Hydrocortisone Butyrate Difluprednate Hydrocortisone Hemisuccinate Dihydrocodeine Hydrogen Tartrate Hydrocortisone Sodium Phosphate Diltiazem HCl Hydrocortisone Sodium Succinate Disopyramide (Upon Request) Hydrocortisone Valerate Dithranol Hyoscine Hydrobromide Doxercalciferol Hyoscine N-butylbromide Drospirenone (Under Development) Hydromorphone HCl Dutasteride (Under Development) Hydroxocobalamin Acetate Hydroxocobalamin Base E Hydroxocobalamin Chloride Enalapril Maleate Hydroxychloroquine Sulphate Eplerenone (Under Development) L-5-Hydroxytryptophan Ergocalciferol Esomeprazole Dihydrate (Under Development) I Esomeprazole Trihydrate Ibuprofen Ethyl Loflazepate Ichthammol Ethylmorphine HCl Imidafenacin (Under Development) Etofenamate Indapamide Exemestane Isoniazid Isopropylmethylphenol (IPMP) F Isopropyl Myristate Fenofibrate Ivabridine HCl (Under Development) Fexofenadine HCl (Upon Request) Ixabepilone (Under Evaluation) Fludrocortisone Fludrocortisone Acetate K Flumethasone Ketamine HCl Flumethasone Pivalate Ketoconazole Flunisolide Ketoprofen Flunisolide Hemihydrate Fluocinolone Acetonide L Fluocinonide Lansoprazole Fluorometholone micronized Leflunomide (Upon Request) Fluprednidene Acetate DL Lysine Acetyl Salicylate (Upon Request) Fluandrenolide (Fludroxycortide) DL Lysine Acetyl Salicylate + Glycine (Upon Fluticasone Furoate (Under Development) Request) Fluticasone Propionate DL Lysine Base 50% Fluticasone Propionate micronized N-Acetyl-DL-Leucine Formoterol Fumarate Lenalidomide (Under Development) Framycetin Sulphate (micro) Levobupivacaine (Under Development) Arena Pharmaceuticals Ltd, Unit 14 Apollo Office Court, Radclive Road, Gawcott, Buckingham, MK18 4DF Tel: + 44 1280 824 200 www.arenapharmaceuticals.co.uk email: [email protected] Arena Product List Levomepromazine HCl Di-L(+)-Ornithine-alfa-oxoglutarate Levomepromazine Maleate L-Ornithine-L-Aspartate Levomethadone HCl (Upon Request) Oxybutynin HCl Levothyroxine Sodium Oxycodone HCl Loprazolam Methanesulfonate Lorazepam P Pancreas Powder M Pantoprazole Sodium Magnesium Glycerophosphate Paramethasone Acetate Magnesium Glycerophosphate 50% Solution Paricalcitol Mecetronium Ethosulphate Pemetrexed Disodium Hemipentahydrate Medroxyprogesterone Acetate Pentoxyifylline Medroxyprogesterone Acetate Sterile Peppermint Oil Megestrol Acetate Pethidine HCl Melatonin Pheniramine Maleate Melphalan HCl Phenobarbital Menthol Laevo Pellets Phenobarbital Sodium Menthol Racemic Phenylephrine HCl Metamizol Magnesium Phenylhydrazine (Upon Request) Metamizol Sodium Phenyltoloxamine Resinate Methacholine Chloride Picosulphate Sodium Methadone HCl Piretanide (Upon Request) Methoxsalen Pitofenone HCl Methylprednisolone Micronized DL-Phosphoserine Methylprednisolone Acetate L-Phosphoserine Methylprednisolone Acetate Micronized L-Phosphothreonine Methylprednisolone Acetate Sterile Piperazine Citrate Methylprednisolone Hemisuccinate Piperazine Phosphate Methylprednisolone Sodium Succinate Sterile Pralidoxime Chloride Metronidoazole Benzoate Micronized Prasugrel HCl (Under Development) Miconazole Base Praziquantel Midazolam HCl Prednicarbate HCl (Upon Request) Midazolam Maleate Prednisolone Hemisuccinate Milnacipran HCl Prednisolone Micronized Micronized Minoxidil Prednisolone Micronized Minoxidil Sulphate Prednisolone Sodium Phosphate Mivacurium Chloride Prednisolone Sodium Metasulfobenzoate Moclobemide Prednisolone Valerate Acetate Modafinil Prednisone Micronized Molsidomine (Upon Request) Prednylidene Mometasone Furoate Pregabalin Mometasone Furoate Monohydrate (Under PRIL Precursors (Upon Request): Development) N-Acetyl-3-chloroalanine methyl ester Morphine Base I:N-(1-S-Carbethoxy-3-phenylpropyl)-S-alanine Morphine HCl Primiquine Diphosphate Morphine Sulfate Primidone Procaine HCl N Promethazine HCl Nalbuphine HCl Propylthiouracil Naloxone HCl Naltrexone HCl Q Naproxen Quetiapine Hemifumarate Natamycin Nedocromil Sodium R Nelarabine (Under Development) Rabeprazole (Under Development) Nimesulide Ramipril Nimesulide Micro Red Clover Extract (IFL 40) Nipagin M Sodium Riboflavine 5 Phosphate Sodium Norepinephrin Hydrogentartrate (Upon Request) Rifampicin Norepinephrin HCl (Upon Request) Rifamycin S (intermediate for Rifampicin) Norgestimate Rifamycin SV Sodium Salt Riluzole (Upon Request) O Ropivacaine HCl (Anhydrous) Octenidine HCl Ropivacaine HCl (Monohydrate) Omeprazole Base Roxithromycin Ondansetron HCl Orange Spirit Compound S Arena Pharmaceuticals Ltd, Unit 14 Apollo Office Court, Radclive Road, Gawcott, Buckingham, MK18 4DF Tel: + 44 1280 824 200 www.arenapharmaceuticals.co.uk email: [email protected] Arena Product List Salmeterol Xinafoate (Under Development) Selegiline HCl (Upon Request) Sildenafil Citrate Sitagliptin Phosphate Mono (Under Development) Sodium Cromoglicate Granules Sodium Cromoglicate Micro Sodium Cromoglicate Milled Sodium Cromoglicate Pellets Sodium Cromoglicate Recrystallised Milled Sodium Hyaluronate Sterile Sodium Stearyl Fumarate Sodium Valproate (Upon Request) Spiramycin Base Spironolactone Micronized Strontium Ranelate Sulindac Sulfadiazine Sulfadimidine Sulfadoxine Sulpiride (Upon Request) Sulphanilamide Sulphathiazole T Tamsulosin HCl (Upon Request) Teicoplanin Tetrazepam (Upon Request) Thymol Thebaine Base Tiaprofenic Acid Ticlopidine HCl Tolterodine (Upon Request) Tolvaptan (Under Development) Topiramate Tramadol HCl Tranexamic Acid Triamcinolone
Load more

Recommended publications
  • Betamethasone
    Betamethasone Background Betamethasone is a potent, long-acting, synthetic glucocorticoid widely used in equine veterinary medicine as a steroidal anti-inflammatory.1 It is often administered intra-articularly for control of pain associated with inflammation and osteoarthritis.2 Betamethasone is a prescription medication and can only be dispensed from or upon the request of a http://en.wikipedia.org/wiki/Betamethasone#/media/File:Betamethasone veterinarian. It is commercially available .png in a variety of formulations including BetaVet™, BetaVet Soluspan Suspension® and Betasone Aqueous Suspension™.3 Betamethasone can be used intra-articularly, intramuscularly, by inhalation, and topically.4 When administered intra-articularly, it is often combined with other substances such as hyaluronan.5 Intra-articular and intramuscular dosages range widely based upon articular space, medication combination protocol, and practitioner preference. Betamethasone is a glucocorticoid receptor agonist which binds to various glucocorticoid receptors setting off a sequence of events affecting gene transcription and the synthesis of proteins. These mechanisms of action include: • Potential alteration of the G protein-coupled receptors to interfere with intracellular signal transduction pathways • Enhanced transcription in many genes, especially those involving suppression of inflammation. • Inhibition of gene transcription – including those that encode pro-inflammatory substances. The last two of these are considered genomic effects. This type of corticosteroid effect usually occurs within hours to days after administration. The genomic effects persist after the concentrations of the synthetic corticosteroid in plasma are no longer detectable, as evidenced by persistent suppression of the normal production of hydrocortisone following synthetic corticosteroid administration.6 When used judiciously, corticosteroids can be beneficial to the horse.
    [Show full text]
  • 268 Part 522—Implantation Or Injectable Dosage Form
    § 520.2645 21 CFR Ch. I (4–1–18 Edition) (ii) Indications for use. For the control 522.82 Aminopropazine. of American foulbrood (Paenibacillus 522.84 Beta-aminopropionitrile. larvae). 522.88 Amoxicillin. 522.90 Ampicillin injectable dosage forms. (iii) Limitations. The drug should be 522.90a Ampicillin trihydrate suspension. fed early in the spring or fall and con- 522.90b Ampicillin trihydrate powder for in- sumed by the bees before the main jection. honey flow begins, to avoid contamina- 522.90c Ampicillin sodium. tion of production honey. Complete 522.144 Arsenamide. treatments at least 4 weeks before 522.147 Atipamezole. main honey flow. 522.150 Azaperone. 522.161 Betamethasone. [40 FR 13838, Mar. 27, 1975, as amended at 50 522.163 Betamethasone dipropionate and FR 49841, Dec. 5, 1985; 59 FR 14365, Mar. 28, betamethasone sodium phosphate aque- 1994; 62 FR 39443, July 23, 1997; 68 FR 24879, ous suspension. May 9, 2003; 70 FR 69439, Nov. 16, 2005; 73 FR 522.167 Betamethasone sodium phosphate 76946, Dec. 18, 2008; 75 FR 76259, Dec. 8, 2010; and betamethasone acetate. 76 FR 59024, Sept. 23, 2011; 77 FR 29217, May 522.204 Boldenone. 17, 2012; 79 FR 37620, July 2, 2014; 79 FR 53136, 522.224 Bupivacaine. Sept. 8, 2014; 79 FR 64116, Oct. 28, 2014; 80 FR 522.230 Buprenorphine. 34278, June 16, 2015; 81 FR 48702, July 26, 2016] 522.234 Butamisole. 522.246 Butorphanol. § 520.2645 Tylvalosin. 522.275 N-Butylscopolammonium. 522.300 Carfentanil. (a) Specifications. Granules containing 522.304 Carprofen. 62.5 percent tylvalosin (w/w) as 522.311 Cefovecin.
    [Show full text]
  • Active Pharmaceutical Ingredients
    Active Pharmaceutical Ingredients Catalog HPD-5E ® CREATING A HEALTHY WORLDTM Active Pharmaceutical Ingredients (APIs) Available for International Markets Human Pharmaceutical Department www.Pharmapex.net Catalog HPD-5E *Not all products referred to on this site are available in all countries and our products are subject to different regulatory requirements depending on the country of use. Consequently, certain sections of this site may be indicated as being intended only for users in specic countries. Some of the products may also be marketed under different trade names. You should not construe anything on this site as a promotion or solicitation for any product or for the use of any product that is not authorized by the laws and regulations of your country of residence. For inquiries about the availability of any specic product in your country, you may simply contact us at [email protected]. **Products currently covered by valid US Patents may be offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk. ©2016, Pharmapex USA, A member of Apex Group of Companies, All Rights Reserved. Toll-Free: 1.844.PHARMAPEX Fax: + 1.619.881.0035 ACTIVE PHARMACEUTICAL [email protected] CREATING A HEALTHY WORLD™ www.Pharmapex.net INGREDIENTS About Pharmapex’s Human Pharmaceuticals Department: Pharmapex’s Human Pharmaceuticals Department (HPD) is a leading source for high-quality Active Pharmaceutical Ingredients (APIs) and Finished Pharmaceutical Products (FPPs) in various markets across the globe. With an extensive product portfolio, our consortium of companies is dedicated to addressing and solving the most important medical needs of our time, including oncology (e.g., multiple myeloma and prostate cancer), neuroscience (e.g., schizophrenia, dementia and pain), infectious disease (e.g., HIV/AIDS, Hepatitis C and tuberculosis), and cardiovascular and metabolic diseases (e.g., diabetes).
    [Show full text]
  • Product Portfolio
    API Product Portfolio Hovione has developed a range of particle engineered Particle Engineered APIs APIs with superior powder properties that will address the challenges of your formulation development. Corticosteroids PRODUCT ROUTE OF CAS CUSTOMIZED REGULATORY ADMINISTRATION NUMBER PARTICLE SIZE STATUS Beclomethasone Dipropionate Anhydrous Inhalation Nasal Oral Topical 5534-09-08 Beclomethasone Dipropionate Monohydrate Inhalation Nasal 77011-63-3 US DMF Betamethasone Acetate Ophtalmic Injectable 987-24-6 US DMF Betamethasone Disodium Phosphate Ophtalmic Injectable Topical 151-73-5 US DMF, JP DMF Fluticasone Furoate Inhalation Nasal 397864-44-7 US DMF CEP, US DMF, JP DMF, Fluticasone Propionate Inhalation Nasal Topical 80474-14-2 CN DMF Halobetasol Propionate Topical 66852-54-8 US DMF Hydrocortisone Aceponate Topical 74050-20-7 ASMF & VMF Mometasone Furoate Anhydrous Inhalation Nasal Topical 83919-23-7 CEP, US DMF, JP DMF Mometasone Furoate Monohydrate Inhalation Nasal 141646-00-6 CEP, US DMF, JP DMF LABA/LAMA PRODUCT ROUTE OF CAS CUSTOMIZED REGULATORY ADMINISTRATION NUMBER PARTICLE SIZE STATUS Aclidinium Bromide Inhalation 320345-99-1 US DMF Glycopyrronium Bromide Inhalation 51186-83-5 US DMF Salmeterol Xinafoate Inhalation 94749-08-3 CEP, US DMF Indacaterol Maleate Inhalation 312753-06-3 DEV Olodaterol Sulphate Inhalation 869477-96-3 DEV Salbutamol Inhalation 18559-94-9 GMP, TECH PACK Tiotropium Bromide Monohydrate Inhalation 136310-93-5 DEV Umeclidinium Bromide Inhalation 869113-09-7 DEV, TECH PACK Vilanterol Trifenatate Inhalation 503070-58-4 GMP, TECH PACK Hovione provides the peace of mind of a high quality Security of supply manufacturer who is a founding member of Rx-360 and has an unblemished regulatory track record.
    [Show full text]
  • Kentucky Horse Racing Commission Withdrawal Guidelines Thoroughbred; Standardbred; Quarter Horse, Appaloosa, and Arabian KHRC 8-020-2 (11/2018)
    Kentucky Horse Racing Commission Withdrawal Guidelines Thoroughbred; Standardbred; Quarter Horse, Appaloosa, and Arabian KHRC 8-020-2 (11/2018) General Notice Unless otherwise specified in these withdrawal guidelines or the applicable regulations and statutes, the following withdrawal guidelines are voluntary and advisory. The guidelines are recommendations based on current scientific knowledge that may change over time. A licensee may present evidence of full compliance with these guidelines to the Kentucky Horse Racing Commission (the “Commission” or “KHRC”) and the stewards as a mitigating factor to be used in determining violations and penalties. These withdrawal interval guidelines assume that administration of medications will be performed at doses that are not greater than the manufacturer’s maximum recommended dosage. Medications administered at dosages above manufacturer’s recommendations, in compounded formulations and/or in combination with other medications and/or administration inside the withdrawal interval may result in test sample concentrations above threshold concentrations that could lead to positive test results and the imposition of penalties. The time of administration of an orally administered substance, for the purposes of withdrawal interval, shall be considered to be the time of complete ingestion of the medication by the horse via eating or drinking. Brand names of medications, where applicable, are listed in parentheses or brackets following the generic name of a drug. In addition to the requirements contained in KRS Chapter 13A, the KHRC shall give notice of an amendment or addition to these withdrawal guidelines by posting the change on the KHRC website and at all Kentucky racetracks at least two weeks before the amendment or addition takes legal effect.
    [Show full text]
  • Betamethasone
    Betamethasone Background Betamethasone is a potent, long-acting, synthetic glucocorticoid widely used in equine veterinary medicine as a steroidal anti-inflammatory.i It is assigned 4/C in the ARCI’s Uniform Classification of Foreign Substances Betamethasone is often administered intra- articularly for control of inflammation associated with osteoarthritisii and other musculoskeletal http://en.wikipedia.org/wiki/Betamethason e#/media/File:Betamethasone.png conditions. Betamethasone is a prescription medication and can only be prescribed, dispensed, or used at the direction of a veterinarian. It is commercially available in a variety of formulations including BetaVet™, BetaVet Soluspan Suspension® and Betasone Aqueous Suspension™.iii Betamethasone can be used intra-articularly, intramuscularly, by inhalation, and topically.iv When administered intra-articularly, it is often combined with other medications such as hyaluronan.v Intra-articular dosages range widely based upon articular space, medication combination protocol, and practitioner preference. Betamethasone is a glucocorticoid receptor agonist that binds to various glucocorticoid receptors triggering a sequence of events affecting gene transcription and the synthesis of proteins. These mechanisms of action include: • Potential alteration of the G protein-coupled receptors to interfere with intracellular signal transduction pathways • Enhanced transcription in many genes, especially those involving suppression of inflammation. • Inhibition of gene transcription – including those
    [Show full text]
  • Bulk Drug Substances Nominated for Use in Compounding Under Section 503B of the Federal Food, Drug, and Cosmetic Act
    Updated June 07, 2021 Bulk Drug Substances Nominated for Use in Compounding Under Section 503B of the Federal Food, Drug, and Cosmetic Act Three categories of bulk drug substances: • Category 1: Bulk Drug Substances Under Evaluation • Category 2: Bulk Drug Substances that Raise Significant Safety Risks • Category 3: Bulk Drug Substances Nominated Without Adequate Support Updates to Categories of Substances Nominated for the 503B Bulk Drug Substances List1 • Add the following entry to category 2 due to serious safety concerns of mutagenicity, cytotoxicity, and possible carcinogenicity when quinacrine hydrochloride is used for intrauterine administration for non- surgical female sterilization: 2,3 o Quinacrine Hydrochloride for intrauterine administration • Revision to category 1 for clarity: o Modify the entry for “Quinacrine Hydrochloride” to “Quinacrine Hydrochloride (except for intrauterine administration).” • Revision to category 1 to correct a substance name error: o Correct the error in the substance name “DHEA (dehydroepiandosterone)” to “DHEA (dehydroepiandrosterone).” 1 For the purposes of the substance names in the categories, hydrated forms of the substance are included in the scope of the substance name. 2 Quinacrine HCl was previously reviewed in 2016 as part of FDA’s consideration of this bulk drug substance for inclusion on the 503A Bulks List. As part of this review, the Division of Bone, Reproductive and Urologic Products (DBRUP), now the Division of Urology, Obstetrics and Gynecology (DUOG), evaluated the nomination of quinacrine for intrauterine administration for non-surgical female sterilization and recommended that quinacrine should not be included on the 503A Bulks List for this use. This recommendation was based on the lack of information on efficacy comparable to other available methods of female sterilization and serious safety concerns of mutagenicity, cytotoxicity and possible carcinogenicity in use of quinacrine for this indication and route of administration.
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2003/0198664 A1 Sullivan Et Al
    US 2003O198664A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2003/0198664 A1 Sullivan et al. (43) Pub. Date: Oct. 23, 2003 (54) LIPID MEDIATED SCREENING OF DRUG Publication Classification CANDDATES FOR IDENTIFICATION OF ACTIVE COMPOUNDS (51) Int. Cl." ......................... C12Q 1/68; G01N 33/574; A61K 9/127; C12N 15/88 (76) Inventors: Sean Michael Sullivan, Gainesville, FL (52) U.S. Cl. ............................. 424/450; 435/6; 435/723; (US); Robert A. Copeland, Hockessin, 435/.458 DE (US) Correspondence Address: (57) ABSTRACT SALIWANCHIK LLOYD & SALWANCHIK A PROFESSIONAL ASSOCATION The Subject invention provides lipoSome formulations that 2421 N.W. 41ST STREET are capable of Specifically targeting cell types. The Subject SUTE A-1 invention also provides for the encapsulation of new chemi GAINESVILLE FL 326066669 cal entities (NCE) or other drug candidate molecules (DCM) 9 within liposomes that Specifically target a particular cell (21) Appl. No.: 10/404,896 type. The Subject invention, advantageously, Solubilizes compounds, with low Solubility in aqueous environments, (22) Filed: Mar. 31, 2003 and permits Screening of these compounds against intact cells for biological activity in the absence of detergents that Related U.S. Application Data can damage cell membranes. Also provided are methods of preparing liposome formulations that target a specific cell (60) Provisional application No. 60/368,529, filed on Mar. type and methods of delivering therapeutic agents to target 29, 2002. cells. US 2003/O198664 A1 Oct. 23, 2003 LPD MEDIATED SCREENING OF DRUG (DCM) within liposomes that specifically target a particular CANDDATES FOR IDENTIFICATION OF ACTIVE cell type. The Subject invention, advantageously, Solubilizes COMPOUNDS compounds, with low Solubility in aqueous environments, and permits Screening of these compounds against intact CROSS-REFERENCE TO RELATED cells for biological activity in the absence of detergents that APPLICATION can damage cell membranes.
    [Show full text]
  • Credentialing Guidelines and Requirements a Candidate Guidebook Table of Contents
    Guidebook Credentialing Guidelines and Requirements A Candidate Guidebook Table of Contents APPENDIX F: CSPT EXAM MEDICATIONS LIST ● CSPT Exam Medications List APPENDIX F: CSPT EXAM MEDICATIONS LIST CSPT Exam Medications List A B Last updated on: January 29, 2021 Guidebook acetaminophen injection bendamustine HCl injection acetazolamide sodium injection betamethasone sodium phosphate/betamethasone acetate injection acetic acid irrigant bevacizumab injection acetylcysteine injection bivalirudin injection acyclovir sodium injection bleomycin sulfate injection adalimumab bupivacaine injection (HCl and liposomal) adenosine injection albumin human injection allopurinol injection alprostadil alteplase recombinant injection amikacin sulfate injection amino acid injection (general formulations) aminophylline (theophylline ethylenediamine) injection amiodarone HCl injection amphotericin B cholesteryl sulfate complex amphotericin B deoxycholate injection amphotericin B lipid complex amphotericin B liposome ampicillin injection ampicillin sodium/sulbactam sodium injection antithymocyte globulin (rabbit) injection argatroban injection asparaginase injection atracurium besylate injection atropine sulfate injection azathioprine sodium injection azithromycin injection aztreonam injection C D Last updated on: January 29, 2021 Guidebook calcium chloride injection dacarbazine injection calcium gluconate injection dactinomycin injection carbamazepine injection daptomycin injection carboplatin injection daunorubicin citrate liposomal injection caspofungin
    [Show full text]
  • PRODUCT CATALOGUE 2021 Available on Product Known Teva Tech US EU Japan Korea Therapeutic Api IP file*** DMF DMF DMF DMF Area**
    S NH2 N N O O O HN CH OH 3 N O SO3H PRODUCT CATALOGUE 2021 Available on www.teva-api.com Product Known Teva Tech US EU Japan Korea therapeutic api IP file*** DMF DMF DMF DMF area** A ABALOPARATIDE Osteoporosis ABEMACICLIB Oncology ABIRATERONE ACETATE Oncology ACALABRUTINIB Oncology AFATINIB Oncology ALCLOMETASONE DIPROPIONATE Dermatology ALLOPURINOL Rheumatology CEP AMCINONIDE Dermatology AMITRIPTYLINE HCl Neurology - Psychiatry CEP ANASTROZOLE Oncology CEP ANIDULAFUNGIN Infectious disease APALUTAMIDE* Oncology Coagulation APIXABAN inhibitors APREMILAST* Psoriasis ARIPIPRAZOLE* Neurology-Psychiatry CEP ATOMOXETINE HCl Neurology-Psychiatry ATORVASTATIN CALCIUM Lipid lowering CEP Preterm labor ATOSIBAN ACETATE prevention ATRACURIUM BESYLATE Muscle relaxant CEP AZACITIDINE Oncology AZITHROMYCIN DIHYDRATE Infectious disease CEP AZITHROMYCIN MONOHYDRATE Infectious disease CEP AZTREONAM* Infectious disease B BALOXAVIR Antiviral 2 Product Known Teva Tech US EU Japan Korea therapeutic api IP file*** DMF DMF DMF DMF area** BARICITINIB Rheumatology BECLOMETHASONE DIPROPIONATE Respiratory CEP BETAMETHASONE ACETATE Inflammation BETAMETHASONE BASE Dermatology CEP BETAMETHASONE DIPROPIONATE Dermatology CEP BETAMETHASONE VALERATE Dermatology CEP BICALUTAMIDE Oncology CEP BIVALIRUDIN Hematology BLEOMYCIN SULFATE Oncology BORTEZOMIB Oncology BREXANOLONE Neurology-Psychiatry BREXPIPRAZOLE Neurology-Psychiatry BROMOCRIPTINE MESYLATE Cardiovascular CEP BUDESONIDE Respiratory CEP BUPRENORPHINE BASE Neurology-Psychiatry CEP BUPRENORPHINE HCl Neurology-Psychiatry
    [Show full text]
  • Prescribing Information Celestone
    PRESCRIBING INFORMATION CELESTONE® SOLUSPAN® (Betamethasone Sodium Phosphate and Betamethasone Acetate Injectable Suspension, USP) intra-articular, intrabursal, intradermal, intramuscular Injectable Glucocorticoid Organon Canada Inc. Date of Revision: April 19, 2021 16766 route Transcanadienne Kirkland, Qc Canada H9H 4M7 www.organon.ca Submission #: 250005 ® N.V. Organon. Used under license. © 2021 Organon Canada Inc. All rights reserved. CELESTONE® SOLUSPAN® (Betamethasone Sodium Phosphate and Betamethasone Acetate Injectable Suspension, USP) PHARMACOLOGICAL CLASSIFICATION Injectable Glucocorticoid PHARMACOLOGY CELESTONE® SOLUSPAN® is a combination of soluble and slightly soluble betamethasone esters that provides potent anti-inflammatory, antirheumatic and antiallergic effects in the treatment of corticosteroid-responsive disorders. Prompt therapeutic activity is achieved by betamethasone sodium phosphate, which is absorbed quickly after injection. Sustained activity is provided by betamethasone acetate, which is only slightly soluble and becomes a repository for slow absorption, thereby controlling symptoms over a prolonged period. INDICATIONS I.M. injection in allergic, dermatologic, rheumatic, and other conditions responsive to systemic corticosteroids, including bursitis; injection directly into the affected tissues in bursitis and associated inflammatory disorders of tendons such as tenosynovitis, and inflammatory disorders of muscle such as fibrosis and myositis; intra-articular and periarticular injection in rheumatoid arthritis
    [Show full text]
  • Appendix B - Product Name Sorted by Applicant
    JUNE 2021 - APPROVED DRUG PRODUCT LIST B - 1 APPENDIX B - PRODUCT NAME SORTED BY APPLICANT ** 3 ** 3D IMAGING DRUG * 3D IMAGING DRUG DESIGN AND DEVELOPMENT LLC AMMONIA N 13, AMMONIA N-13 FLUDEOXYGLUCOSE F18, FLUDEOXYGLUCOSE F-18 SODIUM FLUORIDE F-18, SODIUM FLUORIDE F-18 3M * 3M CO PERIDEX, CHLORHEXIDINE GLUCONATE * 3M HEALTH CARE INC AVAGARD, ALCOHOL (OTC) DURAPREP, IODINE POVACRYLEX (OTC) 3M HEALTH CARE * 3M HEALTH CARE INFECTION PREVENTION DIV SOLUPREP, CHLORHEXIDINE GLUCONATE (OTC) ** 6 ** 60 DEGREES PHARMS * 60 DEGREES PHARMACEUTICALS LLC ARAKODA, TAFENOQUINE SUCCINATE ** A ** AAA USA INC * ADVANCED ACCELERATOR APPLICATIONS USA INC LUTATHERA, LUTETIUM DOTATATE LU-177 NETSPOT, GALLIUM DOTATATE GA-68 AAIPHARMA LLC * AAIPHARMA LLC AZASAN, AZATHIOPRINE ABBVIE * ABBVIE INC ANDROGEL, TESTOSTERONE CYCLOSPORINE, CYCLOSPORINE DEPAKOTE ER, DIVALPROEX SODIUM DEPAKOTE, DIVALPROEX SODIUM GENGRAF, CYCLOSPORINE K-TAB, POTASSIUM CHLORIDE KALETRA, LOPINAVIR NIASPAN, NIACIN NIMBEX PRESERVATIVE FREE, CISATRACURIUM BESYLATE NIMBEX, CISATRACURIUM BESYLATE NORVIR, RITONAVIR SYNTHROID, LEVOTHYROXINE SODIUM ** TARKA, TRANDOLAPRIL TRICOR, FENOFIBRATE TRILIPIX, CHOLINE FENOFIBRATE ULTANE, SEVOFLURANE ZEMPLAR, PARICALCITOL ABBVIE ENDOCRINE * ABBVIE ENDOCRINE INC LUPANETA PACK, LEUPROLIDE ACETATE ABBVIE ENDOCRINE INC * ABBVIE ENDOCRINE INC LUPRON DEPOT, LEUPROLIDE ACETATE LUPRON DEPOT-PED KIT, LEUPROLIDE ACETATE ABBVIE INC * ABBVIE INC DUOPA, CARBIDOPA MAVYRET, GLECAPREVIR NORVIR, RITONAVIR ORIAHNN (COPACKAGED), ELAGOLIX SODIUM,ESTRADIOL,NORETHINDRONE ACETATE
    [Show full text]